GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 371 filers reported holding GLOBUS MED INC in Q4 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,275,959 | -54.4% | 146,545 | -45.3% | 0.03% | -52.1% |
| Q2 2023 | $15,961,007 | +5.6% | 268,072 | +0.5% | 0.07% | +7.6% |
| Q1 2023 | $15,113,251 | -23.8% | 266,830 | -0.1% | 0.07% | -23.3% |
| Q4 2022 | $19,839,819 | +31.6% | 267,131 | +5.5% | 0.09% | +22.9% |
| Q3 2022 | $15,081,000 | +4.6% | 253,156 | -1.4% | 0.07% | +12.9% |
| Q2 2022 | $14,415,000 | -23.7% | 256,762 | +0.3% | 0.06% | -10.1% |
| Q1 2022 | $18,887,000 | +2.3% | 255,995 | +0.1% | 0.07% | +7.8% |
| Q4 2021 | $18,469,000 | -5.0% | 255,803 | +0.8% | 0.06% | -12.3% |
| Q3 2021 | $19,437,000 | -1.1% | 253,687 | +0.1% | 0.07% | +2.8% |
| Q2 2021 | $19,646,000 | +25.8% | 253,397 | +0.1% | 0.07% | +20.3% |
| Q1 2021 | $15,613,000 | -4.9% | 253,173 | +0.6% | 0.06% | -9.2% |
| Q4 2020 | $16,414,000 | +32.2% | 251,678 | +0.4% | 0.06% | +14.0% |
| Q3 2020 | $12,412,000 | +3.6% | 250,642 | -0.2% | 0.06% | -1.7% |
| Q2 2020 | $11,977,000 | +2.5% | 251,031 | -8.6% | 0.06% | -10.8% |
| Q1 2020 | $11,680,000 | -35.0% | 274,632 | -10.0% | 0.06% | -18.8% |
| Q4 2019 | $17,966,000 | +0.6% | 305,132 | -12.7% | 0.08% | -7.0% |
| Q3 2019 | $17,858,000 | +28.8% | 349,334 | +6.5% | 0.09% | +32.3% |
| Q2 2019 | $13,869,000 | -1.7% | 327,871 | +14.9% | 0.06% | -5.8% |
| Q1 2019 | $14,103,000 | +48.3% | 285,420 | +29.9% | 0.07% | +32.7% |
| Q4 2018 | $9,510,000 | +76.9% | 219,732 | +132.0% | 0.05% | +108.0% |
| Q3 2018 | $5,376,000 | +12.3% | 94,711 | -0.2% | 0.02% | +8.7% |
| Q2 2018 | $4,789,000 | +2.5% | 94,901 | +1.2% | 0.02% | 0.0% |
| Q1 2018 | $4,671,000 | +21.3% | 93,751 | +0.0% | 0.02% | +21.1% |
| Q4 2017 | $3,852,000 | -4.4% | 93,733 | -30.9% | 0.02% | -9.5% |
| Q3 2017 | $4,029,000 | +30.6% | 135,562 | +45.6% | 0.02% | +23.5% |
| Q2 2017 | $3,086,000 | +12.2% | 93,081 | +0.2% | 0.02% | +13.3% |
| Q1 2017 | $2,751,000 | +19.4% | 92,860 | -0.0% | 0.02% | +15.4% |
| Q4 2016 | $2,304,000 | – | 92,884 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 373,254 | $26,949,000 | 17.58% |
| Next Capital Management LLC | 111,098 | $8,021,000 | 5.42% |
| Sterling Investment Advisors, Ltd. | 188,123 | $13,582,000 | 3.82% |
| Integral Health Asset Management, LLC | 180,000 | $12,996,000 | 3.60% |
| Pembroke Management, LTD | 602,447 | $43,497,000 | 3.19% |
| Godshalk Welsh Capital Management, Inc. | 73,435 | $5,302,000 | 3.02% |
| XXEC, Inc. | 51,925 | $3,420,000 | 2.92% |
| Sivik Global Healthcare LLC | 75,000 | $5,415,000 | 2.32% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 654,100 | $47,226,000 | 2.11% |
| Van Berkom & Associates Inc. | 929,856 | $67,136,000 | 1.98% |